These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20807815)

  • 1. Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.
    Nair BC; Nair SS; Chakravarty D; Challa R; Manavathi B; Yew PR; Kumar R; Tekmal RR; Vadlamudi RK
    Cancer Res; 2010 Sep; 70(18):7166-75. PubMed ID: 20807815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
    Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
    Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.
    Nagpal JK; Nair S; Chakravarty D; Rajhans R; Pothana S; Brann DW; Tekmal RR; Vadlamudi RK
    Mol Cancer Res; 2008 May; 6(5):851-61. PubMed ID: 18505929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
    Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
    Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
    Chakravarty D; Nair SS; Santhamma B; Nair BC; Wang L; Bandyopadhyay A; Agyin JK; Brann D; Sun LZ; Yeh IT; Lee FY; Tekmal RR; Kumar R; Vadlamudi RK
    Cancer Res; 2010 May; 70(10):4092-101. PubMed ID: 20460518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
    Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
    Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
    Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.
    Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK
    Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.
    Balasenthil S; Vadlamudi RK
    J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional implications of altered subcellular localization of PELP1 in breast cancer cells.
    Vadlamudi RK; Manavathi B; Balasenthil S; Nair SS; Yang Z; Sahin AA; Kumar R
    Cancer Res; 2005 Sep; 65(17):7724-32. PubMed ID: 16140940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of rDNA transcription by proto-oncogene PELP1.
    Gonugunta VK; Nair BC; Rajhans R; Sareddy GR; Nair SS; Vadlamudi RK
    PLoS One; 2011; 6(6):e21095. PubMed ID: 21695158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.
    Altwegg KA; Viswanadhapalli S; Mann M; Chakravarty D; Krishnan S; Liu Z; Liu J; Pratap UP; Ebrahimi B; Sanchez JR; Li X; Ma S; Park BH; Santhamma B; Chen Y; Lai Z; Raj GV; Yuan Y; Zhou D; Sareddy GR; Tekmal RR; McHardy S; Huang TH; Rao MK; Vankayalapati H; Vadlamudi RK
    Cancer Res; 2022 Oct; 82(20):3830-3844. PubMed ID: 35950923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
    Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
    Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PELP1: Structure, biological function and clinical significance.
    Sareddy GR; Vadlamudi RK
    Gene; 2016 Jul; 585(1):128-134. PubMed ID: 26997260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.
    Rajhans R; Vadlamudi RK
    Clin Exp Metastasis; 2006; 23(1):1-7. PubMed ID: 16826428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase-mediated phosphorylation of RBP1 and pRb promotes their dissociation to mediate release of the SAP30·mSin3·HDAC transcriptional repressor complex.
    Suryadinata R; Sadowski M; Steel R; Sarcevic B
    J Biol Chem; 2011 Feb; 286(7):5108-18. PubMed ID: 21148318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells.
    Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L
    Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranuclear coactivator signaling confers insensitivity to tamoxifen.
    Kumar R; Zhang H; Holm C; Vadlamudi RK; Landberg G; Rayala SK
    Clin Cancer Res; 2009 Jun; 15(12):4123-30. PubMed ID: 19470742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PELP1: A novel therapeutic target for hormonal cancers.
    Chakravarty D; Tekmal RR; Vadlamudi RK
    IUBMB Life; 2010 Mar; 62(3):162-9. PubMed ID: 20014005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.